—
C+
C+ The full Closelook — membership. Open the C+ overview

ICON PLC (ICLR) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — ICON PLC

ICLR in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
ICON runs outsourced clinical trial and drug development work for pharmaceutical, biotech and device companies, covering the full path from early compound testing through Phase I-IV studies. It also offers laboratory testing, data analysis, site and patient access, and post-approval commercial support. It is headquartered in Dublin and serves clients across pharmaceuticals, biotechnology, devices and public health bodies.
Where it sits in the stack
ICON carries no seat in our Rubin or Halo indices and sits outside the AI build-out sleeves; the diary places it in the healthcare sector, under diagnostics and research, alongside other clinical research organisations rather than any chip, compute or data-centre layer.
Who it is priced against
Closelook's peer group for ICON is not defined in our records; the market commonly compares it with IQVIA as another large clinical research organisation.
Why Closelook tracks it
ICON carries a Closelook score, but only one module has been scored so far, so the reading is still being built. It has no index seat and appears in two editions, though both quotes concern the ICLR machine-learning conference rather than the company itself, a name overlap rather than dedicated coverage of its business.
What the diary watches
The diary watches whether pharmaceutical and biotech sponsors keep outsourcing trial management at the same pace, since ICON's order book depends on that spending holding up.

ICON PLC (ICLR) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for ICLR, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is ICON PLC (ICLR)?

ICON PLC trades as ICLR on the US exchange (US) in the Closelook research universe, as of the registry build of 2026-09-18.

Is ICLR in a Closelook index?

Not currently — ICON PLC is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does ICLR trade against its moving averages?

Uptrend stack intact: Trades +1.4% vs the 50-day and +15.2% vs the 200-day average, 16.8% below the 52-week high and +154.9% off the 52-week low; a golden cross printed 39 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does ICON PLC do?

ICON runs outsourced clinical trial and drug development work for pharmaceutical, biotech and device companies, covering the full path from early compound testing through Phase I-IV studies. It also offers laboratory testing, data analysis, site and patient access, and post-approval commercial support. It is headquartered in Dublin and serves clients across pharmaceuticals, biotechnology, devices and public health bodies. Closelook's peer group for ICON is not defined in our records; the market commonly compares it with IQVIA as another large clinical research organisation.

Where does ICON PLC sit in the AI build-out?

ICON carries no seat in our Rubin or Halo indices and sits outside the AI build-out sleeves; the diary places it in the healthcare sector, under diagnostics and research, alongside other clinical research organisations rather than any chip, compute or data-centre layer. ICON carries a Closelook score, but only one module has been scored so far, so the reading is still being built. It has no index seat and appears in two editions, though both quotes concern the ICLR machine-learning conference rather than the company itself, a name overlap rather than dedicated coverage of its business.

Where has Closelook written about ICON PLC?

ICON PLC appears in 2 Closelook pieces, most recently Report: Google and RSI — The Loop Nobody Has Closed (2026-09-13); Daily Pulse: The Opex Handover — Why the AI Trade Is Rotating, Not Rolling Over (2026-06-30). What Closelook said most recently: The International AI Safety Report 2026 devotes a section to it, and ICLR 2026 ran a workshop with recursive self-improvement in the title. (Report, 2026-09-13). The "Mentioned on Closelook" block on this page lists the long reads, the reference entries and the dailies that name it.

What does this page show?

A live price chart with SMA overlays and drawing tools for ICLR, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Mentioned on Closelook 2 pieces · newest: Report, “Google and RSI — The Loop Nobody Has Closed” (2026-09-13)

Mentioned on Closelook

Where ICLR appears in the diary — 2 pieces, newest first. Every link is our own writing.

Long reads

Dailies

Related in the Closelook universe